Format

Send to

Choose Destination
Expert Rev Mol Diagn. 2011 Jan;11(1):53-64. doi: 10.1586/erm.10.101.

Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications.

Author information

1
The American University in Cairo, 113 Kasr El-Aini Street, Cairo 11511, Egypt.

Abstract

Molecular diagnostic assays represent a cornerstone in the management of hepatitis C virus (HCV) patients. Qualitative and quantitative HCV molecular assays are used for the diagnosis of acute and chronic HCV infections, viral genotyping, viral-load determination, treatment monitoring and prognosis. Reverse-transcription PCR, transcription-mediated amplification and branched DNA amplification are commonly employed for detection of HCV RNA. Recently, new HCV molecular assays that employ nanostructures have emerged and have been proposed as suitable for both low- and high-resource settings, without sacrificing sensitivity and specificity. This article will present current and future HCV molecular diagnostic assays with a focus on their clinical applications.

PMID:
21171921
DOI:
10.1586/erm.10.101
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center